The Cancer Research Institute (CRI) hosted its 22nd Annual International Cancer Immunotherapy Symposium October 6-8, 2014 at The Grand Hyatt in New York City. Attracting clinicians, laboratory scientists, postdoctoral fellows, and graduate students, the symposium featured plenary presentations from leaders in immunology and cancer immunotherapy, a poster session, and numerous networking opportunities.
The CRI symposium, entitled Cancer Immunotherapy: Out of the Gate, harnessed the excitement and enthusiasm generated by recent clinical successes to explore new and emerging areas of basic, translational, and clinical research. Topics such as the use of genomic methods to catalogue cancer heterogeneity, mechanistic studies of checkpoint blockage antibodies, new views on immunosurveillance and immunoregulation, and emerging therapies that are altering the landscape of cancer treatment was discussed.
New This Year: CIC Satellite Meeting
New to the meeting this year, CRI hosted a special Cancer Immunotherapy Consortium (CIC) satellite meeting on October 5 entitled Development of Surrogate Endpoints for Cancer Immunotherapy Trials. The meeting consisted of a full day of presentations and panel discussions addressing the key rationale, challenges, and solutions surrounding the development of surrogate endpoints for cancer immunotherapy. This meeting represented the culmination of a CIC-led community-wide effort that brought together the major stakeholders in the field, including experts from industry, academia, and regulatory bodies as well as patients. The output of the meeting will be a consensus-driven roadmap for the efficient regulatory approval of future immunotherapies.
Cancer Immunotherapy 2014 Planning Committee
James P. Allison, The University of Texas MD Anderson Cancer Center
Glenn Dranoff, Dana-Farber Cancer Institute
Carl F. Nathan, Weill Cornell Medical College
Ellen Puré, University of Pennsylvania School of Veterinary Medicine
Robert D. Schreiber, Washington University School of Medicine
Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center